Star Combo Pharma Ltd
ASX:S66

Watchlist Manager
Star Combo Pharma Ltd Logo
Star Combo Pharma Ltd
ASX:S66
Watchlist
Price: 0.12 AUD 9.09% Market Closed
Market Cap: 16.2m AUD
Have any thoughts about
Star Combo Pharma Ltd?
Write Note

Intrinsic Value

S66 doesn't have a meaningful market cap.

The intrinsic value of one S66 stock under the Base Case scenario is 0.13 AUD. Compared to the current market price of 0.12 AUD, Star Combo Pharma Ltd is Undervalued by 10%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

S66 Intrinsic Value
0.13 AUD
Undervaluation 10%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Star Combo Pharma Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for S66 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about S66?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Consumer products Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Star Combo Pharma Ltd

Provide an overview of the primary business activities
of Star Combo Pharma Ltd.

What unique competitive advantages
does Star Combo Pharma Ltd hold over its rivals?

What risks and challenges
does Star Combo Pharma Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Star Combo Pharma Ltd.

Provide P/S
for Star Combo Pharma Ltd.

Provide P/E
for Star Combo Pharma Ltd.

Provide P/OCF
for Star Combo Pharma Ltd.

Provide P/FCFE
for Star Combo Pharma Ltd.

Provide P/B
for Star Combo Pharma Ltd.

Provide EV/S
for Star Combo Pharma Ltd.

Provide EV/GP
for Star Combo Pharma Ltd.

Provide EV/EBITDA
for Star Combo Pharma Ltd.

Provide EV/EBIT
for Star Combo Pharma Ltd.

Provide EV/OCF
for Star Combo Pharma Ltd.

Provide EV/FCFF
for Star Combo Pharma Ltd.

Provide EV/IC
for Star Combo Pharma Ltd.

Compare the intrinsic valuations
of Star Combo Pharma Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Star Combo Pharma Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Star Combo Pharma Ltd compared to its peers.

Compare the P/E ratios
of Star Combo Pharma Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Star Combo Pharma Ltd with its peers.

Analyze the financial leverage
of Star Combo Pharma Ltd compared to its main competitors.

Show all profitability ratios
for Star Combo Pharma Ltd.

Provide ROE
for Star Combo Pharma Ltd.

Provide ROA
for Star Combo Pharma Ltd.

Provide ROIC
for Star Combo Pharma Ltd.

Provide ROCE
for Star Combo Pharma Ltd.

Provide Gross Margin
for Star Combo Pharma Ltd.

Provide Operating Margin
for Star Combo Pharma Ltd.

Provide Net Margin
for Star Combo Pharma Ltd.

Provide FCF Margin
for Star Combo Pharma Ltd.

Show all solvency ratios
for Star Combo Pharma Ltd.

Provide D/E Ratio
for Star Combo Pharma Ltd.

Provide D/A Ratio
for Star Combo Pharma Ltd.

Provide Interest Coverage Ratio
for Star Combo Pharma Ltd.

Provide Altman Z-Score Ratio
for Star Combo Pharma Ltd.

Provide Quick Ratio
for Star Combo Pharma Ltd.

Provide Current Ratio
for Star Combo Pharma Ltd.

Provide Cash Ratio
for Star Combo Pharma Ltd.

What is the historical Revenue growth
over the last 5 years for Star Combo Pharma Ltd?

What is the historical Net Income growth
over the last 5 years for Star Combo Pharma Ltd?

What is the current Free Cash Flow
of Star Combo Pharma Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Star Combo Pharma Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Star Combo Pharma Ltd

Current Assets 18.4m
Cash & Short-Term Investments 7.4m
Receivables 4.5m
Other Current Assets 6.5m
Non-Current Assets 24.5m
PP&E 23.1m
Intangibles 677.2k
Other Non-Current Assets 684.7k
Current Liabilities 4.9m
Accounts Payable 4m
Accrued Liabilities 437.5k
Other Current Liabilities 385.4k
Non-Current Liabilities 4.6m
Long-Term Debt 3.9m
Other Non-Current Liabilities 747.9k
Efficiency

Earnings Waterfall
Star Combo Pharma Ltd

Revenue
26.3m AUD
Cost of Revenue
-20.3m AUD
Gross Profit
6m AUD
Operating Expenses
-4.8m AUD
Operating Income
1.2m AUD
Other Expenses
-436.4k AUD
Net Income
747.3k AUD

Free Cash Flow Analysis
Star Combo Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

S66 Profitability Score
Profitability Due Diligence

Star Combo Pharma Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
ROIC is Increasing
Positive Gross Profit
Positive 1-Year Revenue Growth
35/100
Profitability
Score

Star Combo Pharma Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

S66 Solvency Score
Solvency Due Diligence

Star Combo Pharma Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Low D/E
Negative Net Debt
53/100
Solvency
Score

Star Combo Pharma Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

S66 Price Targets Summary
Star Combo Pharma Ltd

There are no price targets for S66.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for S66?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for S66 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Star Combo Pharma Ltd Logo
Star Combo Pharma Ltd

Country

Australia

Industry

Consumer products

Market Cap

16.2m AUD

Dividend Yield

3.08%

Description

Star Combo Pharma Ltd. engages in the manufacture and distribution of vitamis, dietary supplements, and skincare products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2018-05-16. The firm develops, manufactures, and distributes a range of branded vitamins, dietary supplements, and skincare products, serving both domestic and offshore markets. The firm operates through two segments: Star Combo business and Austoyou retail. Star Combo business segment includes developing, manufacturing, marketing and sales of natural health supplements and skin care products. Austoyou retail business made up of the Australia-China e-commerce platform that offers products directly to Chinese health product consumers; and Koala Mall’s two retail stores in Sydney. Its products include Costar NMN, Costar osteo comples Gluco, Living Healthy and Little, Amax Top Marine Collagen E ,J&K Ultra nourishing colla and J&K Rose Oil Lanolin Cream. The company also provides Original Equipment Manufacturer (OEM) Services and Quality Assurance.

Contact

NEW SOUTH WALES
Sydney
Smithfield, 171 - 177 Woodpark Road
+61297566555.0
www.starcombo.com.au

IPO

2018-05-16

Employees

-

Officers

CEO & Executive Director
Ms. Su Zhang M.B.A.
Founder, MD & Director
Mr. JinXing Zhang B.S.
Chief Financial Officer
Mr. James Ni
Chief Operating Officer
Mr. He Ben B.S.
Company Secretary
Mr. Patrick James Raper F.A.C.I.D., FAICD, FCPA

See Also

Discover More
What is the Intrinsic Value of one S66 stock?

The intrinsic value of one S66 stock under the Base Case scenario is 0.13 AUD.

Is S66 stock undervalued or overvalued?

Compared to the current market price of 0.12 AUD, Star Combo Pharma Ltd is Undervalued by 10%.

Back to Top